Marvell (MRVL) PT Raised to $125 at Wolfe Research

Wolfe Research analyst Chris Caso raised the price target on Marvell (NASDAQ: MRVL) to $125.00 (from $85.00) while maintaining a Outperform rating.

The analyst comments "MRVL reported F3Q/F4Q mostly inline but provided guidance thru FY28, suggesting nearly $5 earnings power driven by an acceleration in DC revenue. We expect the stock can move higher from current levels as MRVL executes on its opportunities. Reiterate OP, raise PT to $125."

You May Also Be Interested In

• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat